Nintedanib Impurity 6 (Intedanib Impurity 6)

Overview

BIBF 1202 is the major in-vivo metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR. It is a related compound of Intedanib, which is an indolinone derivative that inhibits angiokinase and an antitumor agent. It is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (VEGF) signaling pathway thus inhibition of tumor angiogenesis.

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Nintedanib and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-474893
• CAS No.: 894783-71-2
• Molecular Formula: C30H31N5O4
• Molecular Weight: 525.60
• Purity: >98%
• Storage: -20°C Freezer
• Solubility: DMSO: ≥ 45 mg/mL

Source

Original product source